Table 3 Antenatal and delivery characteristics by maternal status at 42 days after delivery, 2010–2018 all clusters
Characteristica | N(%) by maternal status | Total | Risk Ratio(95% CI)b | |
|---|---|---|---|---|
Women who died | Women alive six weeks after delivery | |||
Deliveries, N | 842 | 570,479 | 571,321 | |
No antenatal care (vs. any antenatal care) | 62/834 (7.4) | 20,426/570,105 (3.6) | 20,488/570,939 (3.6) | 1.6 (1.1, 2.4) |
Fewer than 4 antenatal care visits (vs. > 4 visits) | 339/605 (56.0) | 201,105/447,076 (45.0) | 201,444/447,681 (45.0) | 1.3 (1.1, 1.7) |
Birth attendant | 620 | 570,351 | 570,971 | |
Physician | 291 (46.9) | 203,294 (35.6) | 203,585 (35.7) | 1.0 |
Nurse/Midwife/Health worker | 131 (21.1) | 203,325 (35.6) | 203,456 (35.6) | 0.4 (0.3, 0.5) |
Traditional birth attendant | 134 (21.6) | 119,738 (21.0) | 119,872 (21.0) | 0.5 (0.4, 0.7) |
Family/Self/Other | 64 (10.3) | 43,994 (7.7) | 44,058 (7.7) | 0.8 (0.6, 1.0) |
Delivery location | 623 | 570,402 | 571,025 | |
Hospital | 335 (53.8) | 244,926 (42.9) | 245,261 (43.0) | 1.0 |
Clinic/health center | 113 (18.1) | 170,980 (30.0) | 171,093 (30.0) | 0.4 (0.3, 0.5) |
Home/other | 175 (28.1) | 154,496 (27.1) | 154,671 (27.1) | 0.6 (0.5, 0.8) |
Delivery mode | 612 | 545,759 | 546,371 | |
Vaginal | 424 (69.3) | 466,355 (85.5) | 466,779 (85.4) | 1.0 |
Vaginal assisted | 19 (3.1) | 5364 (1.0) | 5383 (1.0) | 3.3 (1.7, 6.5) |
Caesarean section | 169 (27.6) | 74,040 (13.6) | 74,209 (13.6) | 2.7 (2.3, 3.3) |
Obstructed labor | 148/697 (21.2) | 44,947/569,869 (7.9) | 45,095/570,566 (7.9) | 3.0 (2.3, 3.9) |
Fetal Malpresentation | 45/692 (6.5) | 11,253/569,773 (2.0) | 11,298/570,465 (2.0) | 3.3 (2.4, 4.4) |
Severe antepartum hemorrhage | 71/695 (10.2) | 8783/569,937 (1.5) | 8854/570,632 (1.6) | 6.7 (5.0, 9.0) |
Hypertensive disorders | 156/688 (22.7) | 14,650/569,679 (2.6) | 14,806/570,367 (2.6) | 10.6 (8.5, 13.2) |
Maternal treatment provided | ||||
Maternal antibiotics | 350/559 (62.6) | 229,932/464,473 (49.5) | 230,282/465,032 (49.5) | 2.3 (1.8, 2.9) |
Corticosteroids | 43/439 (9.8) | 10,225/413,905 (2.5) | 10,268/414,344 (2.5) | 4.0 (2.8, 5.9) |
Oxytocics (including Misoprostol) | 344/556 (61.9) | 308,315/463,555 (66.5) | 308,659/464,111 (66.5) | 0.9 (0.7, 1.1) |
Blood transfusion | 186/560 (33.2) | 9789/464,309 (2.1) | 9975/464,869 (2.1) | 20.9 (16.0, 27.2) |
Removal of retained products | 45/558 (8.1) | 20,750/464,252 (4.5) | 20,795/464,810 (4.5) | 2.1 (1.4, 3.1) |
Anticonvulsants/Magnesium sulfate | 60/553 (10.8) | 5692/464,277 (1.2) | 5752/464,830 (1.2) | 9.8 (7.2, 13.4) |
V Fluids | 182/258 (70.5) | 90,672/173,017 (52.4) | 90,854/173,275 (52.4) | 2.4 (1.7, 3.4) |
Forceps/vacuum | 13/254 (5.1) | 1908/172,354 (1.1) | 1921/172,608 (1.1) | 4.3 (2.4, 7.7) |
Other surgery/treatment | 22/255 (8.6) | 9830/172,810 (5.7) | 9852/173,065 (5.7) | 1.7 (1.1, 2.7) |